Walleye Trading
RVLP

Walleye Trading’s RVL Pharmaceuticals plc Ordinary Shares RVLP Stock Holding History

Walleye Trading’s Portfolio RVLP Stock Details RVLP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-10,000
Closed -$30K – 6047
2021
Q3 		$30K Hold
10,000
– – ﹤0.01% 4779
2021
Q2 		$30K Hold
10,000
– – ﹤0.01% 4754
2021
Q1 		$33K Buy
+10,000
New +$41.1K ﹤0.01% 4441
2020
Q3 		– Sell
-12,500
Closed -$84K – 4750
2020
Q2 		$84K Buy
+12,500
New +$61.2K ﹤0.01% 3602
2020
Q1 		– Sell
-16,000
Closed -$112K – 4736
2019
Q4 		$112K Buy
+16,000
New +$85.4K ﹤0.01% 3505

Other funds holding RVLP

ACM
Athyrium Capital Management New York $8.69M AUM 34.58% 1-Year Est. Return
RA
Rovida Advisors Fort Lauderdale, Florida $116M AUM 12.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Walleye Trading's RVLP Position: Q4 2021 in Review

Walleye Trading sold out of RVL Pharmaceuticals plc Ordinary Shares (RVLP) in Q4 2021, closing a stake of 10,000 shares — an estimated $30K sold.

Walleye Trading first reported a position in RVLP in Q4 2019 and held it in 5 quarters. The position peaked at $112K in Q4 2019. 31 funds tracked by Wall St. Rank hold RVLP as of Q4 2021.

  • Walleye Trading reported no remaining RVL Pharmaceuticals plc Ordinary Shares position as of Q4 2021 after selling out during the quarter.
  • Walleye Trading sold 10,000 RVL Pharmaceuticals plc Ordinary Shares shares in Q4 2021, an estimated $30K.
  • Walleye Trading first reported a position in RVL Pharmaceuticals plc Ordinary Shares in Q4 2019 and held it in 5 quarters.
  • Walleye Trading's RVL Pharmaceuticals plc Ordinary Shares position peaked at $112K in Q4 2019.
  • 31 funds tracked by Wall St. Rank held RVL Pharmaceuticals plc Ordinary Shares as of Q4 2021.

Based on Walleye Trading's 13F filing for Q4 2021, filed 14 Feb 2022.